Daren Heyland1, Xuran Jiang2, Andrew G Day2, Michel Laverdiere3. 1. Department of Medicine, Queen's University, Kingston, ON, Canada; Critical Care, Queen's University, Kingston, ON, Canada; Clinical Evaluation Research Unit, Kingston General Hospital, Kingston, ON, Canada K7L 2V7. Electronic address: dkh2@queensu.ca. 2. Clinical Evaluation Research Unit, Kingston General Hospital, Kingston, ON, Canada K7L 2V7. 3. Department of Microbiology-Infectious Diseases Hopital Maisonneuve-Rosemont, Montreal, QC, Canada H1T 2M4.
Abstract
BACKGROUND: The purpose of this pilot study was to determine whether β-d-glucan (BG) was associated with Candida in the lung and risk of death in patients with suspected ventilator-associated pneumonia (VAP). METHODS: In a single-center observational study, we enrolled eligible adults within 24 hours of intensive care unit admission. Patients who developed suspected VAP were divided into 3 groups according to culture results. Serum BG levels and clinical outcomes were collected. RESULTS: Fifty-seven patients were included; 26 had no growth, 19 patients grew pathogenic bacteria only, and 12 patients grew only Candida. The proportion of patients with a positive BG tended to be greater in the Candida group (66.7% vs 26.3% in bacteria group vs 50.0% in culture-negative group, P = .09). The BG-positive patients were much more likely to die by day 28 than the BG-negative patients (odds ratio, 4.2; 95% confidence limits, 1.1-15.7; P = .03). Patients with both BG positivity and Candida in their lung secretions were much more likely to die compared with patients who did not. CONCLUSIONS: β-d-Glucan positivity in patients with a suspected VAP may be a marker for Candida in the lung and worse outcomes. Further validation of this postulate is warranted.
BACKGROUND: The purpose of this pilot study was to determine whether β-d-glucan (BG) was associated with Candida in the lung and risk of death in patients with suspected ventilator-associated pneumonia (VAP). METHODS: In a single-center observational study, we enrolled eligible adults within 24 hours of intensive care unit admission. Patients who developed suspected VAP were divided into 3 groups according to culture results. Serum BG levels and clinical outcomes were collected. RESULTS: Fifty-seven patients were included; 26 had no growth, 19 patients grew pathogenic bacteria only, and 12 patients grew only Candida. The proportion of patients with a positive BG tended to be greater in the Candida group (66.7% vs 26.3% in bacteria group vs 50.0% in culture-negative group, P = .09). The BG-positive patients were much more likely to die by day 28 than the BG-negative patients (odds ratio, 4.2; 95% confidence limits, 1.1-15.7; P = .03). Patients with both BG positivity and Candida in their lung secretions were much more likely to die compared with patients who did not. CONCLUSIONS: β-d-Glucan positivity in patients with a suspected VAP may be a marker for Candida in the lung and worse outcomes. Further validation of this postulate is warranted.
Authors: Greet De Vlieger; Katrien Lagrou; Johan Maertens; Eric Verbeken; Wouter Meersseman; Eric Van Wijngaerden Journal: J Clin Microbiol Date: 2011-08-31 Impact factor: 5.948
Authors: M Hoenigl; J Prattes; B Spiess; J Wagner; F Prueller; R B Raggam; V Posch; W Duettmann; K Hoenigl; A Wölfler; C Koidl; W Buzina; M Reinwald; C R Thornton; R Krause; D Buchheidt Journal: J Clin Microbiol Date: 2014-03-26 Impact factor: 5.948
Authors: Elitza S Theel; Deborah J Jespersen; Seher Iqbal; Jean E Bestrom; Leonard O Rollins; Lori J Misner; Barbara J Markley; Jayawant Mandrekar; Larry M Baddour; Andrew H Limper; Nancy L Wengenack; Matthew J Binnicker Journal: Mycopathologia Date: 2012-09-01 Impact factor: 2.574
Authors: Thomas P Hellyer; Andrew Conway Morris; Daniel F McAuley; Timothy S Walsh; Niall H Anderson; Suveer Singh; Paul Dark; Alistair I Roy; Simon V Baudouin; Stephen E Wright; Gavin D Perkins; Kallirroi Kefala; Melinda Jeffels; Ronan McMullan; Cecilia M O'Kane; Craig Spencer; Shondipon Laha; Nicole Robin; Savita Gossain; Kate Gould; Marie-Hélène Ruchaud-Sparagano; Jonathan Scott; Emma M Browne; James G MacFarlane; Sarah Wiscombe; John D Widdrington; Ian Dimmick; Ian F Laurenson; Frans Nauwelaers; A John Simpson Journal: Thorax Date: 2014-10-08 Impact factor: 9.102
Authors: Georgios D Kitsios; Daniel Kotok; Haopu Yang; Malcolm A Finkelman; Yonglong Zhang; Noel Britton; Xiaoyun Li; Marina S Levochkina; Amy K Wagner; Caitlin Schaefer; John J Villandre; Rui Guo; John W Evankovich; William Bain; Faraaz Shah; Yingze Zhang; Barbara A Methé; Panayiotis V Benos; Bryan J McVerry; Alison Morris Journal: JCI Insight Date: 2021-07-22